Company profile
Pfizer Inc.
NYSE: PFE · Healthcare · Drug Manufacturers - General
#13 of 1,418 Healthcare companies by revenue39th-percentile growth
EA Score
76B+FH 78DQ 84GM 40SS 99
v0.1 · 65/100 weight · provisional
↑ listing tenure, market scale · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$63.3B
Rev growth YoY (TTM)
+1.4%
Net income (FY)
$7.8B
Employees
75,000
as of 2026-08-04
Market cap
$142.7B
as of 2026-08-04
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$62.6B$62.6B2025
Net income$7.8B$7.8B2025
Total assets$208.2B$208.2B2025
Liabilities$121.4B$121.4B2025
Equity$86.5B$86.5B2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY23
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Biopharma98%
Segment Reporting, Reconciling Item, Corporate Nonsegment2%
By geography
UNITED STATES59%
Developed Rest Of World26%
Emerging Markets15%
The read
What is Pfizer Inc.’s revenue?
Pfizer Inc. booked $62.6B in FY2025 revenue, contracting 1.6% year over year — slower than 61% of Healthcare companies we track, at a 12.4% net margin.
Peers · Healthcare
HCA Healthcare, Inc.78B+Eli Lilly and Company93AMerck & Co., Inc.84B+AbbVie Inc.81B+Bristol-Myers Squibb Company85AMolina Healthcare, Inc.83B+Neighbors
New York →Key facts
CEOAlbert Bourla
SectorHealthcare
IndustryDrug Manufacturers - General
HeadquartersNew York City, NY
ExchangeNYSE: PFE
Employees75,000
IPO date1972-06-01
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.